Comparative characteristics of uropathogenic Escherichia coli strains, allocated in polyclinic and stationary conditions


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The etiological structure of urinary tract infections (UTI) is determined by the leading role of uropathogenic Escherichia coli (UPEC). The aim of the work is to study the biological properties and phylogenetic diversity of E. coli strains isolated from UTI in outpatient and inpatient patients. Methods and materials. 198 clinical UPEC strains were studied, 105 of which were designated as polyclinic and 93 as nosocomial (73 are isolated from urine and 20 are from catheter surface 48 hours after hospitalization). UPEC phylogenetic groups were determined by polymerase chain reaction (quadruplex PCR) according to O. Clermont et al. (2013). Results. Among polyclinic cultures, representatives of all eight recognizable phylogroups were found; strains of UPEC phylogroup B2 (37.1%), E (13.3%) and F (8.6%) were most often found. Nosocomial cultures in almost 90% of cases belonged to the phylogroup B2, to which all the catheter-associated strains were assigned. The E. coli of the phylogroup B2, both in the mono-species and in the polymicrobial associations, was authentically more often isolated in the hospital than in the polyclinic (p<0.00001), whereas the bacteria of the phylogroup E, on the contrary, in the polyclinic (p<0.0001) . The hemolytic activity and biofilm-forming ability of UPEC strains did not differ in the two groups, while in the hospital hemolytic E. coli of the B2 phylogroup was significantly more likely than the polyclinic (p<0.001). In addition, B2 strainsformed biofilms in more than 60% cases. Regardless of the source of isolation, the strains were resistant to ampicillin (62.1%), amoxicillin/clavulanate (27.8%), cefotaxime (37.9%) and ciprofloxacin (36.9%). The production of ESBL was detected in fifty-one (25.8%) cultures, with a statistically significant difference in nosocomial strains: urinary

Full Text

Restricted Access

About the authors

M. V Kuznetsova

«Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences»

Email: mar@iegm.ru,mar19719@yandex.ru
Dr.Med.Sci., leading researcher of Laboratory

S. V Provorova

PRO-MED LLC Microbiological laboratory

Email: pro-svet68@yandex.ru
Chief

O. G Kubarev

«Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences»

Email: oleg_kubarev@mail.ru
Ph.D. student at the Laboratory of Molecular Diagnosis and Biotechnology

D. S Yudin

Perm State National Research University

Email: roll_96@mail.ru
student of Biological Faculty

N. V Karimova

«Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences»

Email: ber6a@list.ru
Ph.D. student at the Laboratory of Molecular Diagnosis and Biotechnology

N. V Bajandina

PRO-MED LLC Microbiological laboratory

Email: natalia.baiandina.79@mail.ru
bacteriologist

M. A Teplyakova

«Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences»

Email: tepl.margari@yandex.ru
bacteriologist

V. A Demakov

«Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences»; Perm State National Research University

Email: demakov@iegm.ru
Dr.Med.Sci., corresponding member of RAS, Chief

References

  1. Grabe M., Bjerklund-Johansen T.E., Botto H., Cek M., Naber K.G., Pickard R.S., Tenke P., Wagenlehner F., Wullt B. Urological infections. European Guidelines. 2011;115 p.
  2. Wiles T.J., Kulesus R.R., Mulvey M.A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. l^ol. Eathol. 2008;5:11-19. doi: 10.1016/j.yexmp.2008.03.007.
  3. Soto S.M. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv. Biol. 2014;13:543974. ID 543974.
  4. Nicolle L.E. Catheter associated urinary tract infections. Antimicrob. Resist. Inf. Control. 2014;3(23):1-8. doi: 10.1186/2047-2994-3-23.
  5. Hola V., Ruzicka F. The Formation of poly-microbial biofilms on urinary catheters. urinary tract infections, Dr. Peter Tenke (Ed.), ISBN: 978-953-307-757-4, InTech Available from: http://www.intechopen.com/books/ urinary-tract-infections/the-formation-of-poly-microbial-biofilms-on-urinarycatheters.
  6. Бухарин О.В., Гриценко ВА., Вялкова А.А. Факторы уропатогенности бактерий: роль в патогенезе и значение в диагностике пиелонефрита. Нефрология и диализ. 2001;3(4):469-475
  7. Перепанова Т.С. Значение инфекций, обусловленных образованием биопленок, в урологической практике. Эффективная фармакотерапия. 2013;37:18-27
  8. Kanamaru S., Kurazono H., Nakano M., Terai A., Ogawa O., Yamamoto S. Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: comparison with phylogenetic groups. Int. J. Urol. 2006;13:754-760. doi: 10.1111/j.1442-2042.2006.01398.x.
  9. Lee J.H., Subhadra B, Kim D.H., Park H.S., Kim J.M., Koo S.H., Oh M.H., Choi C.H. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lett. App. Microbiol. 2015;62:84-90. doi: 10.1111/lam.12517.
  10. Millân Y., Hernàndez E., Millàn B., Araque M. Distribution of phylogenetic groups and virulence factors in CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli strains isolated from patients in the community of Mérida, Venezuela. Rev. Argent. Microbiol. 2014;46(3):175-81. doi: 10.1016/S0325-7541(14)70069-0.
  11. Munkhdelger Y. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J. Infect. Dev. Ctries. 2017;11(1):51-57. doi: 10.3855/jidc.7903.
  12. Grude N., Potaturkina-Nesterovä N.I., Jenkins A., Strand L., Nowrouzian F.L., Nyhus J., Kristiansen B.E. A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection. Clinical Microbiology and Infection. 2007;13(2):208-211. doi: 10.1111/j.1469-0691.2006.01584.x.
  13. Kumar N., Nahid F., Zahra R. Association of virulence factors, phylogenetic groups and antimicrobial resistance markers in Escherichia coli from Badin city, Pakistan. J. Chemother. 2017;29(1):8-13. doi: 10.1080/112000 9X.2016.1154682.
  14. O’Toole G.A., Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 1998;30:295- 304. doi: 10.1046/j.1365-2958.1998.01062.x.
  15. Clermont O., Christenson J.K., Denamur E., Gordon D.M. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 2013;1:58-61. doi: 10.1111/1758-2229.12019.
  16. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015; 13(5):269-284. doi: 10.1038/nrmicro3432.
  17. Katouli M. Population structure of gut Escherichia coli and its role in development of extra-intestinal infections. Iran. J. Microbiol. 2010;2(2): 59-72.
  18. Коган М.И., Набока Ю.Л., Беджанян С.К., Митусова Е.В., Гудима И.А., Моргун П.П., Васильева Л.И. Информативно ли бактериологическое исследование пузырной мочи при остром обструктивном пиелонефрите? Урология. 2017;3:10-15). Doi: https:// dx.Doi.org/10.18565/urol.2017.3.10-15.
  19. Шамхалова М.Ш., Чугунова Л.А. Инфекции мочевых путей у больных сахарным диабетом: диагностика, профилактика, лечение. Методические рекомендации. Международный эндокринологический журнал. 2005 ;2(2). [Электронный ресурс] http://www.mifua.com/archive/article/2253
  20. Kline K.A., Lewis A.L. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiol. Spectr. 2016;4(2). doi: 10.1128/microbiolspec.UTI-0012-2012.
  21. Matthews S.J., Lancaster J.W. Urinary tract infections in the elderly population. Am. J. Geriatr. Pharmacother. 2011;9:286-309.
  22. Warren J.W., Tenney J.H., Hoopes J.M., Muncie H.L., Anthony W.C. А. prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 1982;146(6):719-723. doi: 10.1093/infdis/146.6.719.
  23. Galvan E.M., Mateyca C., Ielpi L. Role of interspecies interactions in dual-species biofilms developed in vitro by uropathogens isolated from polymicrobial urinary catheter associated bacteriuria. Biofouling. 2016;32(9):1067-1077. doi: 10.1080/08927014.2016.1231300.
  24. Bishara J., Leibovici L., Huminer D., Drucker M., Samra Z., Konisberger H., Pitlik S. Five-year prospective study of bacteraemic urinary tract infection in a single institution. Eur. J. Clin. Microbiol. Infect. Dis. 1997;16(8):563-567.
  25. Тец Г.В., Тец В.В., Ворошилова Т.М. Метагеномный анализ проб при цистите. Урология. 2016; 1:37-44
  26. Tenaillon O., Skurnik D., Picard B., Denamur E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 2010;8(3):207-217. doi: 10.1038/nrmicro2298.
  27. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000;10:4555-4558. doi: 10.1128/AEM.66.10.4555-4558.2000.
  28. Logue C.M., Wannemuehler Y., Nicholson B.A., Doetkott C., Barbieri N.L., Nolan L.K. Comparative analysis of phylogenetic assignment of human and avian ExPEC and fecal commensal Escherichia coli using the (previous and revised) Clermont phylogenetic typing methods and its impact on avian pathogenic Escherichia coli (APEC) classification. Front. Microbiol. 2017;8:283. doi: 10.3389/fmicb.2017.00283.
  29. Iranpour D., Hassanpour M., Ansari H., Tajbakhsh S., Khamisipour G., Najafi A. Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new Clermont phylotyping method. Bioned. Res. Int. 2015;846219. ID 846219. doi: 10.1155/2015/846219.
  30. Skjot-Rasmussen L., Ejrnæs K., Lundgren B., Frimodt-Moller N. Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin. Int. J. Med. Microbiol. 2012;302(3):129-134. doi: 10.1016/j.ijmm.2012.03.002.
  31. Turrientes M.-C., González-Alba J.-M., del Campo R., Baquero M.-R., Canton R., Baquero F., Galan J.-C. Recombination blurs phylogenetic groups routine assignment in Escherichia coli: setting the record straight. PLoS One. 2014;9(11):e113532.
  32. Fatima N., Agrawal M., Shukla I., Khan P.A. Characterization of uropathogenic E. coli in relation to virulence factors. Scientific Reports. 2012;1(7):342. doi: 10.4172/scientificreports.
  33. Ejrnæs K., Stegger M., Reisner A., Ferry S., Monsen T., Holm S.E., Lundgren B., Frimodt-Moller N. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence. 2011 ;2(6):528-537. Doi: 10.4161/ viru.2.6.18189.
  34. Палагин И.С., Сухорукова М.В., Дехнич А.В., Эйдельштейн М.В., Шевелев А.Н, Гринев А.В., Перепанова Т.С., Козлов Р.С. Современное состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты исследования «ДАРМИС» (2010-2011). Клиническая микробиология и антимикробная химиотерапия. 2012;14(4):280-302
  35. Ali I., Kumar N., Ahmed S., Dasti J.I. Antibiotic resistance in uropathogenic E. coli strains isolated from non-hospitalized patients in Pakistan. J. Clin. Diagn. Res. 2014;8(9):1-4. doi: 10.7860/JCDR/2014/7881.4813.
  36. Rijavec M., Erjavec Starcic M., Avgustin Ambrozic J., Reissbrodt R., Fruth A., Krizan-Hergouth V., Zgur-Bertok D. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr. Microbiol. 2006;53:158-162. doi: 10.1007/s00284-005-0501-4.
  37. Petty N.K., Ben Zakour N.L., Stanton-Cook M., Skippington E., Totsika M., Forde B.M., Phan M.D. et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc. Natl. Acad. Sci. USA. 2014;111(15):5694-5699. doi: 10.1073/pnas.1322678111.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies